Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
NCT04496427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2020-08-03
Summary
This is an observational study to determine the efficacy and safety of Potenfill for temporary penile enhancement.
The pivotal study of Potenfill has already been completed and this observational study determines the long-term efficacy and safety for up to 24 months in subjects who have been participated and treated in the pivotal study.
Conditions
- Penile Enhancement
Sponsors & Collaborators
-
Medy-Tox
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-10
- Primary Completion
- 2019-11-15
- Completion
- 2019-12-11
Countries
- South Korea
Study Locations
More Related Trials
-
Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction
NCT03933995 ·Status: UNKNOWN
-
External Device for Erectile Dysfunction (3D-Erect)
NCT04624126 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction
NCT03039504 ·Status: COMPLETED ·Phase: NA
-
Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction
NCT02665520 ·Status: UNKNOWN ·Phase: PHASE2
-
Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ?
NCT04390230 ·Status: UNKNOWN
-
Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
NCT00903981 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction
NCT01901640 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction
NCT01774864 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
NCT05188989 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
NCT01065012 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction
NCT02477436 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
NCT02667938 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety of TPN171H Tablet in Erectile Dysfunction.
NCT06301854 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
NCT02495467 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Testosterone in Men With Erectile Dysfunction
NCT00512707 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Erectile Dysfunction I
NCT01037244 ·Status: COMPLETED ·Phase: PHASE3
-
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
NCT00422734 ·Status: COMPLETED ·Phase: PHASE3
-
This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.
NCT01705197 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
NCT02496845 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
NCT05388825 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
NCT03813992 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia
NCT00668135 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction
NCT02224846 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
NCT06968494 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Clinical Efficacy of Precious Metal Fiber Textile (Germanium Titanium π Element) for Erectile Dysfunction
NCT03359265 ·Status: COMPLETED ·Phase: NA